Nebula Research & Development LLC Has $566,000 Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nebula Research & Development LLC trimmed its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 28.6% during the fourth quarter, Holdings Channel reports. The firm owned 82,125 shares of the company’s stock after selling 32,837 shares during the quarter. Nebula Research & Development LLC’s holdings in Nu Skin Enterprises were worth $566,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Meeder Asset Management Inc. bought a new position in Nu Skin Enterprises in the 4th quarter valued at about $25,000. US Bancorp DE increased its stake in shares of Nu Skin Enterprises by 424.2% in the 4th quarter. US Bancorp DE now owns 7,460 shares of the company’s stock valued at $51,000 after purchasing an additional 6,037 shares during the last quarter. Signaturefd LLC raised its holdings in shares of Nu Skin Enterprises by 536.8% during the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company’s stock worth $56,000 after buying an additional 6,817 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Nu Skin Enterprises by 2,412.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company’s stock worth $57,000 after buying an additional 7,888 shares in the last quarter. Finally, Bank of Montreal Can acquired a new position in shares of Nu Skin Enterprises during the 4th quarter worth $80,000. 82.84% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Tuesday, April 8th.

Nu Skin Enterprises Stock Up 1.2 %

Shares of NYSE:NUS opened at $5.84 on Tuesday. The business’s 50 day simple moving average is $7.03 and its two-hundred day simple moving average is $6.95. The firm has a market cap of $290.38 million, a P/E ratio of -1.98 and a beta of 1.10. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. Nu Skin Enterprises, Inc. has a 52-week low of $5.32 and a 52-week high of $14.00.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The company had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. As a group, research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were given a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 4.11%. Nu Skin Enterprises’s payout ratio is currently -8.14%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.